Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EA-230 in patients at risk of acute renal failure after major cardiac on-pump surgery
2007-007132-25Phase 2Terminated
- Sponsor
- EBI
- Start
- Feb 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EA-230 in acute kidney failure (AKF) (3 arms), sponsored by EBI. Primary endpoint: Maximum change in serum creatinine from baseline. Started Feb 2009; status: terminated.
02
Drugs
EA-230
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2007-007132-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007132-25.